z-logo
Premium
Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA
Author(s) -
Mehta Shikha G.,
Chang Jae H.,
Alhamad Tarek,
Bromberg Jonathan S.,
Hiller David J.,
Grskovic Marica,
Yee James P.,
Man Roslyn B.
Publication year - 2019
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15192
Subject(s) - medicine , cell free fetal dna , kidney transplant , dna , renal transplant , kidney transplantation , kidney , immunology , genetics , biology , pregnancy , fetus , prenatal diagnosis
In 2015, 13% of recipients of kidney transplants in the United States were repeat transplants for prior allograft failure (1). These repeat kidney transplant recipients (RKTR) have inferior graft survival and a higher risk of rejection to that of single kidney transplant recipients (SKTR) (1, 2). In spite of these risks, transplant patients benefit from a repeat transplant compared to dialysis support (3). The use of noninvasive biomarkers of allograft injury may optimize the care of RKTR. This article is protected by copyright. All rights reserved.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here